SUMMARY Trypsin in duodenal aspirate and pure pancreatic juice samples has been measured by both radioimmunoassay and enzymatic methods. The radioimmunoassay has been shown to be specific and to detect trypsin in the presence of aprotinin (Trasylol). In duodenal juice samples from control subjects and from patients with primary biliary cirrhosis a good correlation was obtained between both immunoreactive trypsin concentration and trypsin activity. The immunoreactive trypsinogen concentration in pure pancreatic juice also correlated well with activated trypsin activity. The mean immunoreactive trypsin concentration and the concentration of enzymatically inert immunoreactive trypsin in duodenal juice samples from patients with primary biliary cirrhosis were significantly lower than controls, suggesting pancreatic hyposecretion in this disease. After five duodenal juice samples had been stored for three months at -700C, immunoreactive trypsin concentration in samples stored without Trasylol were reduced by 12 0±4.2 (mean±SD) times the concentration of samples stored in Trasylol. Trypsin autodegradation continues even at -70°C; Trasylol protects against this. Radioimmunoassay is a reliable method of trypsin estimation in duodenal juice and has advantages over conventional enzymatic analysis.
A radioimmunoassay technique is available for the measurement of trypsin in human serum. ' The present study describes the use of this assay for the measurement of trypsin in duodenal juice and in pure pancreatic juice and compares the radioimmunoassay with a conventional method of enzymatic analysis. Since the radioimmunoassay also detects inhibitor-bound trypsin, it can be used in the estimation of the enzyme in duodenal juice which has been stored in the presence of inhibitors. In the absence of inhibitors, trypsin is known to autodegrade.2 Unlike enzymatic methods, the radioimmunoassay will also detect inactive proenzymes; it can therefore be used to measure trypsinogen in pure pancreatic juice without prior activation with enterokinase. Finally, in an attempt to test the hypothesis that the conversion of trypsinogen to trypsin in the duodenum may be impaired in primary biliary cirrhosis because of the low intraduodenal bile acid concentrations,34 we have assayed the trypsin content of duodenal juice from patients with this disease by both methods simultaneously and compared the data with those from normal subjects.
Received for publication 1 1 December 1979 Methods CONTROLS Duodenal juice samples from 31 fasting subjects (22 males; age 20-72 years) were collected after the intravenous administration of cholecystokinin-pancreoxymin (100 Crick-Harper-Raper, CHR, units Boots Co., Nottingham, UK) and secretin (100 units Boots Co.), via a single lumen Ryle's Trypsin activity in duodenal juice was measured by a spectrophotometric method6 based on the rate of hydrolysis of p-tosyl-l-arginine methyl ester. Trypsinogen in pure pancreatic juice was assayed similarly, after activation by incubating at 37°C for 40 minutes with duodenal juice of known trypsin activity which had been diluted 1 in 20 with 46 mM Tris buffer containing 33 mM CaCI2, pH 8-1 for 40 minutes.7 The trypsin activity in the duodenal juice sample used for activating the pure pancreatic juice samples was subtracted from the total.
Immunoreactive trypsin concentration was determined by radioimmunoassay (RIA-gnost Trypsin, Behringwerke, Marburg). Details of the assay and its use in the estimation of serum trypsin have been previously described.1 Preliminary results showed that tryptic activity in samples of duodenal juice from four normal subjects were completely inhibited by Trasylol at a dilution of 1 in 2. As an additional precaution, all samples of duodenal juice were diluted 1 in 4 with Trasylol to ensure complete inhibition. Other dilutions were made with bovine serum albumin (5 g%). determination of trypsin is shown in Fig. 1 . Lyophilised human trypsin standards were diluted in either distilled water or in Trasylol. The radioactivity from radiolabelled trypsin bound to antibody at increasing trypsin concentrations was similar both in the presence or absence of Trasylol. Trasylol therefore does not cross-react with the antibody under the assay conditions.
ANTIBODY SPECIFICITY
In an attempt to verify the specificity of the radioimmunoassay for trypsin, duodenal juice samples were used from which both trypsin and chymotrypsin had been removed by passage through an affinity column containing soybean trypsin inhibitor coupled to CNBr-activated Sepharose 4B (Pharmacia, Uppsala, Sweden). The column was eluted with 0-1 M NaHCO3 buffer containing 0.5 M NaCI at pH 7-8. The protein material eluted contained no tryptic activity. The percentage trace binding at increasing concentrations of protein material remained constant up to 68 ,ug per ml. Above this, a decrease in the amount of bound tracer was observed. At a protein concentration of 272 ,ug/ml, 375 ng/ml of trypsin was detected by radioimmunoassay. The radioimmunoassay of trypsin in normal duodenal juice is usually performed at a 1 in 1000 dilution. At these high dilutions (total protein concentration approximately 1 ,ug/ml), interference due to proteins other than trypsin would be minimal. Chymotrypsin' was eluted from the, STk-sepharosecolumn by the addition of tryptamine (0.013 M) to the buffer. Even at concentrations of up to 736 ,ug/ml, the mixture of purified human chymotrypsin and tryptamine did not affect the binding of antibody to radiolabelled trypsin.
EFFECT OF PROTEIN
The effect of varying concentrations of protein on the recovery of trypsin in duodenal juice by the radioimmunoassay was studied. A sample of duodenal juice was assayed after dilution in albumin solutions of varying concentrations, from 1 to 8 g/100 ml. In five experiments the mean trypsin concentration measured was 358±38 (mean±SD) and ranged from 320 ,ug/ml to 429 ,ug/ml. Varying the concentration of protein between 1 and 8 g/ 100 ml does not appear to affect the measurement of trypsin in duodenal juice. EFFECT Fig. 4 Correlation between immunoreactive trypsin concentration and enzymatic activity in duodenaljuice samples from patients with primary biliary cirrhosis (r=O088, p <O0001, y=0.023 x+148S5). They-intercept, 1485 gg/ml, is 32.5 % of the mean total immunoreactive trypsin concentration, 457 ztg/ml.
1800-
1600. Trypsin Activity (UIL x 10-3) enzymatic activity and immunoreactive trypsin concentration (r=0-75, P<0 001) in duodenal juice (Fig. 3) . The equation of the linear regression line is given by y=0.04 x+296.1, where y is the immunoreactive trypsin concentration and x is enzymatic activity. The intercept when x=0, y=296 ,ug/ml may represent the amount of immunoreactive trypsin which is enzymatically inactive and may be either trypsin which is bound to inhibitors, inert trypsin, or trypsinogen.
Primary biliary cirrhosis
The normal conversion of trypsinogen to trypsin by enterokinase requires the presence of bile and bile acids.34 In the absence of bile acids in the duodenum in children with biliary atresia, abnormally low trypsin activities were found in duodenal aspirate, whereas chymotrypsin activity was normal. This was thought to represent incomplete trypsinogen activation.3 In 35 samples of duodenal juice collected from six patients with primary biliary cirrhosis, a good correlation was found between immunoreactive trypsin concentration and trypsin activity (r= 0.88, p< 0.001) (Fig. 4) (Fig. 5) . The intercept of the regression`line when trypsin activity was zero gave the equivalent concentration of immunoreactive trypsin as 607 ,ug/ml. The mean immunoreactive trypsin concentration in the pure pancreatic juice samples, 926±39 ,ug/ml, did not differ significantly from the duodenal juice samples from controls, 912±540 gg/ml (t=0.09, p<0.4; unpaired Student's t test).
Effect of storage at -70°C Aliquots of duodenal juice were stored at -70°C for three months, with and without Trasylol. Trypsin concentration was then measured in the samples by radioimmunoassay. Results are shown in Fig. 6 . The concentrations of immunoreactive trypsin measured in the five samples stored in Trasylol were 12-0±4.2 (mean±SD) times higher than in identical samples stored without Trasylol. Trasylol thus appears to offer protection against autodegradation which can occur even at -70°C.
Discussion
These results confirm that measurement of duodenal juice trypsin by radioimmunoassay is a useful alternative to enzymatic analysis. Our data, like the findings of Temler and Felber,9 confirm that inhibition of the catalytic activity of trypsin does not interfere with its immunoreactivity. The radioimmunoassay therefore offers two major advantages. Firstly, trypsin can be estimated in duodenal juice which has been stored in Trasylol to eliminate autodegradation. Secondly, as the inactive zymogen can also be measured, trypsinogen in pure pancreatic juice can be estimated directly without the need for prior activation.
The loss of immunoreactive trypsin in the samples of duodenal juice stored at -70°C without Trasylol was unexpected. It suggests that significant proteolytic activity continues even at this low temperature.
Lyophilised samples of trypsin have previously been observed to show slow autodigestion at 40C.10 Trasylol (Bayer, Germany) is a polypeptide obtained from bovine lung, with reversible antiproteinase activity against trypsin and chymotrypsin. The higher recoveries of trypsin in duodenal juice in the presence of Trasylol probably result from the inhibition of trypsin digestion by chymotrypsin and by trypsin itself (Fig. 2) . Albumin, on the other hand, will reduce trypsin digestion from all the proteolytic enzymes in duodenal juice by providing substrate competition. This probably accounts for the higher recoveries in the presence of albumin. The protein is equally effective at all concentrations between 1 and 8 g/l. 
